Overall, our results—in combination with previous studies—suggest that sLOX-1 is a biomarker for atherosclerotic disease of the blood vessels, which is minimally associated with the major cardiovascular risk factors and demographic features that are usually used in primary prevention risk models for CAD. Here, OLR1 is linked to coronary artery disorder.